Chip-concentrated stocks clustered in four major industries, and 43 stocks fell for more than three consecutive periods. According to the statistics of Securities Times and DataBao, as of December 12, 300 stocks disclosed the number of shareholders in the latest period, compared with the previous period (November 30), there were 162 stocks with a decrease in the number of shareholders. Specifically, the number of shareholders in 29 stocks decreased by more than 5%, and the number of shareholders in 5 stocks decreased by more than 10%, including Dongfang Huanyu, Zhongshe, Baina Qiancheng, Midland New Materials and Hengshuai. Many chip-concentrated stocks have performed well in the recent market. According to the statistics of DataBao, the average share capital of 126 chips has increased by 4.86% since last month, and the cumulative increase of 18 stocks is above 10%. The top gainers are Guoan Da, Beiwei Technology and Silk Road Vision, which have increased by 42.5%, 26.18% and 21.44% respectively. From the industry point of view, the number of chip concentrated stocks is the largest in the four major industries of mechanical equipment, power equipment, electronics, medicine and biology.The dual platform of transaction detection has landed in Henan to cultivate the diamond industry to a higher level. Recently, the Zhengzhou International Trading Center for Cultivating Diamonds (to be established) and the Henan Laboratory of Jewelry National Inspection Group, which are jointly established by China Jewelry and Jade Jewelry Industry Association and Jewelry National Inspection Group, were officially unveiled in Zhengzhou Airport Area, marking a key step in cultivating the industrial layout of diamonds in Henan Province, which is of great significance for promoting regional economic development and industrial upgrading. "With unified and authoritative product standards, the market can establish a sound pricing mechanism and further promote the extension of the industrial chain." During the interview, people in the industry told the reporter of Company E that this time, the Jewelry National Inspection Group landed in Henan, which will further provide inspection services close to the place of origin, reduce the cost of cultivating diamonds and establish professional evaluation standards. At the same time, the trading center will also set up a platform to cultivate the diamond price trading index, standardize the market pricing system, and stabilize prices and market supply and demand. In the future, Zhengzhou Airport Port Area will also rely on the trading center to build and cultivate the downstream industrial chain layout of diamond processing, design and inlay in the area, and base on the advantages of the airport to maximize the value of the industrial chain."Shanghai housing subsidy is 300,000 yuan" and "down payment is 20,000 yuan to buy 1.8 million hardcover existing houses"? Rumor has come. Recently, there have been a number of housing advertisements on the short video platform. The agent who released the housing claimed that he could receive the "housing subsidy" when buying a house in Shanghai, with the amount ranging from 200,000 yuan to 300,000 yuan. An intermediary declared: "Shanghai Songjiang New Town has a total price of 760,000 yuan and a housing subsidy of 250,000 yuan." "After receiving the subsidy, you can buy a 78-square-meter house with a down payment of 50,000 yuan." There is also an intermediary who claims: "The minimum payment can be only 20,000 yuan, and you can buy a finely decorated existing house with a total price of 1.8 million yuan." The reporter consulted a number of intermediaries and learned that the so-called "purchase subsidies" appearing in short videos are not government subsidies, but gimmicks. When the house-watchers consult subsidies on the spot, different intermediaries will have different calibers. Usually, there are three routines-one is to raise the price first and then lower the price. Second, the so-called "subsidy" is actually that developers lend money to buyers to pay down payment, and buyers have to pay interest. Third, the commission returned by the intermediary to the buyers is packaged as a "subsidy". (Shanghai rumor platform)
Lantu Automobile expanded its intelligent driving team on a large scale and set up a special recruitment session for employees of Extreme Vietnam. Lantu Automobile released a total of 800+ jobs nationwide, of which the development positions in the intelligent driving and intelligent cabin fields accounted for over 80%, which was the first time that Lantu Automobile publicly recruited intelligent high-end talents on a large scale. According to Lantu, the company has set up relevant technical posts in Beijing, Shanghai, Wuhan and other places. In addition, Lantu has also set up a national recruitment special session covering many positions for employees. At present, more than 200 technical developers are actively communicating with Lantu.Market information: FTSE Film will increase the output of CMP slurry in Korea by 30%.Debon Securities: Contemporary Amperex Technology Co., Limited has deepened its sea going, strengthened its globalization and maintained its "buy" rating. Debon Securities Research Report pointed out that Contemporary Amperex Technology Co., Limited (300750.SZ) plans to establish a joint venture with STELLANTIS in Spain, with an estimated total investment of 4.038 billion euros. This project will deepen the long-term strategic cooperative relationship between Contemporary Amperex Technology Co., Limited and Stellantis, the world's leading automobile manufacturer, in the field of new energy vehicles, and promote the global electrification and clean energy transformation by giving full play to their respective leading advantages and resources. Considering that the company is the industry leader, its supply chain integration ability is excellent, and the iteration of new products is accelerated, maintaining the "buy" rating.
The onshore RMB against the US dollar closed at 7.2795 at 16:30 on December 13th, down 165 points from the previous trading day.The US dollar index rose by 0.3%, the Japanese yen fell to 153, and the Swiss franc fell by over 0.9%. On Thursday (December 12), the ICE dollar index rose by 0.31% to 107.038 points, and the intraday trading range was 106.354-107.041 points. The whole day showed a volatile upward state, but the European Central Bank announced a rate cut, the US PPI data was released, and Beijing. The Bloomberg dollar index rose by 0.28%, reaching a daily high of 1288.41 points, and then fluctuated upward after reaching a daily low of 1281.12 points at 15:17. The dollar rose 0.14% against the yen to 152.67 yen, and the intraday trading range was 151.81-152.77 yen. The euro fell 0.27% to 1.0467, the pound fell 0.62% to 1.2673, and the dollar rose 0.93% to 0.8924 against the Swiss franc. Among the commodity currencies, the Australian dollar was roughly flat after falling back against the US dollar, while the New Zealand dollar fell by 0.29% and the US dollar rose by 0.44% against the Canadian dollar. The Swedish krona fell 0.38% against the US dollar, while the Norwegian krona fell 0.26% against the US dollar.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.